Microbiome therapy shows promise for preventing deadly bloodstream infections in early trial

AI Summary

Researchers from City of Hope and collaborators are testing a therapy containing 16 selected beneficial bacteria to restore the microbiome in patients receiving donor stem cell transplants for blood cancers. Early trial findings suggest the approach may help prevent dangerous bloodstream infections.

Researchers at City of Hope and collaborators have pioneered a new approach to preventing dangerous bloodstream infections in patients receiving donor stem cell transplants for blood cancers. The first-of-its-kind therapy delivers 16 carefully selected beneficial bacteria designed to restore the microbiome and fight harmful pathogens.